Developments in biomarkers and treatment strategies for chronic lung diseases

E-poster
Chairs: M. Platé (London, United Kingdom), P. BARDIN (Champs-sur-Marne, France)
Aims: This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.

FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA R. Razumnyi (Dnipro, Ukraine)
Community acquired pneumonia in COPD patients: ?linical features and peculiarities of nitric oxide metabolism U. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation), E. Amirova (Ufa (Republic of Bashkortostan), Russian Federation), R. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation)
Active oxygen forms and antioxidant blood status in patients with community acquired pneumonia and its combination with COPD U. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation), E. Amirova (Ufa (Republic of Bashkortostan), Russian Federation), R. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation), S. Farkhutdinov (Ufa (Republic of Bashkortostan), Russian Federation)
Role of peroxidases in the formation of an osmo-dependent reaction of airways in patients with asthma J. Perelman (Blagoveshchensk, Russian Federation), A. Pirogov (Blagoveshchensk, Russian Federation), A. Prikhodko (Blagoveshchensk , Russian Federation), V. Kolosov (Blagoveshchensk , Russian Federation)
The effect of antioxidants on oxidative metabolism in smokers S. Soodaeva (Moscow, Russian Federation), I. Klimanov (Moscow, Russian Federation), E. Zaprudnova (Vladimir, Russian Federation), L. Churkina (Vladimir, Russian Federation), T. Li (Moscow, Russian Federation), N. Popova (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), V. Novoselov (Pushino, Russian Federation), L. Nikitina (Moscow, Russian Federation)
The leucocyte telomere length, GSTM1 and GSTT1 null genotypes and the risk of COPD T. Tacheva (Stara Zagora, Bulgaria), S. Zienolddiny (Oslo, Norway), D. Dimov (Stara Zagora, Bulgaria), H. Notø (Oslo, Norway), D. Vlaykova (Stara Zagora, Bulgaria), A. Haugen (Oslo, Norway), T. Vlaykova (Stara Zagora; Plovdiv, Bulgaria)
The Involvement of NLRX1 in Pulmonary Hyperoxic Acute Injury. H. Kim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), E. Kim (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea)
The proinflammatory role of SOCS3 in COPD is regulated by the expression of miRNAs in Bronchoalveolar Lavage (BAL) microvesicles (MV) M. Tinè (Padova (PD), Italy), E. Bazzan (Padova (PD), Italy), S. Carpi (Pisa (PI), Italy), B. Polini (Pisa (PI), Italy), T. Neri (Pisa (PI), Italy), A. Casara (Padova (PD), Italy), M. Cecchini (Pisa (PI), Italy), P. Nieri (Pisa (PI), Italy), A. Celi (Pisa (PI), Italy), M. Saetta (Padova (PD), Italy), M. Cosio (Montreal, Canada)
Oxalate excretion in patients with allergic airway diseases I. Klimanov (Moscow, Russian Federation), S. Soodaeva (Moscow, Russian Federation), E. Tush (Nizhny Novgorod, Russian Federation), A. Obykhov (Nizhny Novgorod, Russian Federation), D. Ovsyannikov (Nizhny Novgorod, Russian Federation), S. Vanyakina (Nizhny Novgorod, Russian Federation), O. Khaletskaya (Nizhny Novgorod, Russian Federation), M. Glukhova (Moscow, Russian Federation), L. Nikitina (Moscow, Russian Federation)
Plasma derived-exosome microRNAs in Idiopathic Pulmonary Fibrosis of Anti-synthetase syndrome Disease patients S. Bozzini (Pavia, Italy), G. Zanframundo (Pavia, Italy), V. Codullo (Pavia, Italy), V. Frangipane (Pavia, Italy), L. Pandolfi (Pavia, Italy), S. Lettieri (Pavia, Italy), B. Atienza-Mateo (Santander, Spain), S. Remuzgo Martinez (Santander, Spain), C. Montecucco (Pavia, Italy), M. Gonzalez-Gay (Santander, Spain), L. Cavagna (Pavia, Italy), F. Meloni (Pavia, Italy)
D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study S. Pini (Milan, Italy), M. Saad (Milan, Italy), E. Franceschi (Milan, Italy), L. Perotto (Milan, Italy), G. Croce (Milan, Italy), F. Giuliani (Milan, Italy), A. Airoldi (Milan, Italy), M. Rizzi (Milan, Italy), D. Radovanovic (Milan, Italy), P. Santus (Milan, Italy), D. Radovanovic (Milano (MI), Italy)
Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia C. Suarez (Palma de Mallorca, Spain), J. Sauleda Roig (Palma de Mallorca, Spain), N. Calvo Rado (Palma de Mallorca, Spain), S. Hermoso De Mendoza Aristegui (Palma de Mallorca, Spain), L. Ramon Clar (Palma de Mallorca, Spain), B. Nuñez Sanchez (Palma de Mallorca, Spain), A. Iglesias Coma (Palma de Mallorca, Spain), L. Noje Noje (Palma de Mallorca, Spain), A. Alonso Fernandez (Palma de Mallorca, Spain), D. Morell García (Palma de Mallorca, Spain), M. Rodriguez Romero (Palma de Mallorca, Spain), N. Toledo Pons (Palma de Mallorca, Spain), J. Valera Felices (Palma de Mallorca, Spain), J. Martinez Menendez (Palma de Mallorca, Spain), J. Palmer Sancho (Palma de Mallorca, Spain), J. Pons De Ves (Palma de Mallorca, Spain), E. Sala Llinas (Palma de Mallorca, Spain)
Improved assay for the quantification of hydroyproline (collagen) in animal models of Idiopathic Pulmonary Fibrosis. M. Mcelroy (Edinburgh (Edinburgh), United Kingdom), J. Davis (Edinburgh (Edinburgh), United Kingdom), A. Marsden (Edinburgh (Edinburgh), United Kingdom), P. Filis (Edinburgh (Edinburgh), United Kingdom), D. Spark (Edinburgh (Edinburgh), United Kingdom), I. Love (Edinburgh (Edinburgh), United Kingdom)
The effect of pulmonary macrophage transplantation in the pulmonary fibrosis of mice E. SUZUKI (Chiba, Japan), J. Ikari (Chiba, Japan), M. Suzuki (Chiba, Japan), A. Shimada (Chiba, Japan), K. Yamamoto (Chiba, Japan), N. Tanaka (Chiba, Japan), A. Sekine (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan), T. Suzuki (Chiba, Japan)
Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis M. Bonatti (Parma, Italy), V. Pitozzi (Parma, Italy), P. Caruso (Parma, Italy), S. Pontis (Parma, Italy), M. Pittelli (Parma, Italy), C. Frati (Parma, Italy), D. Madeddu (Parma, Italy), F. Quaini (Parma, Italy), C. Lagrasta (Parma, Italy), M. Civelli (Parma, Italy), S. Ottonello (Parma, Italy), G. Villetti (Parma, Italy), M. Trevisani (Parma, Italy), B. Montanini (Parma, Italy)
Development of PRS-220, a potential best-in-class, inhaled CTGF/CCN2 inhibitor for the treatment of IPF V. Welk (Hallbergmoos, Germany), M. Pavlidou (Hallbergmoos, Germany), C. Wurzenberger (Hallbergmoos, Germany), E. Hansbauer (Hallbergmoos, Germany), C. Wurzenberger (Hallbergmoos, Germany), S. Grüner (Hallbergmoos, Germany), J. Peper-Gabriel (Hallbergmoos, Germany), T. Jaquin (Hallbergmoos, Germany), A. Konitsiotis (Hallbergmoos, Germany), J. Morgenstern (Hallbergmoos, Germany), J. Prassler (Hallbergmoos, Germany), G. Matschiner (Hallbergmoos, Germany), S. Olwill (Hallbergmoos, Germany)
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice R. O'Donoghue (Melbourne, Australia), C. O'Brien (Melbourne, Australia), M. Chuei (Melbourne, Australia), V. Welk (Freising, Germany), T. Jaquin (Freising, Germany), G. Martic (Freising, Germany), E. Cho (Melbourne, Australia), K. Stok (Melbourne, Australia), D. Haugan (Melbourne, Australia), G. Matschiner (Freising, Germany), G. Ciccotosto (Melbourne,, Australia), A. Jarnicki (Melbourne, Australia), G. Anderson (Melbourne, Australia)
The effect of roflumilast on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice H. Joo (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), J. Kim (Seoul, Republic of Korea)
Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model O. Titova (St. Petersburg, Russian Federation), N. Kuzubova (St. Petersburg, Russian Federation), E. Lebedeva (St. Petersburg, Russian Federation), E. Volchkova (St. Petersburg, Russian Federation)
Late Breaking Abstract - Changes in human bronchial epithelial cell (BEC) DNA 5-methylcytosine (mC) And 5-hydroxymethylcytosine (hmC) in response to Nepal cook stove smoke exposure P. Rajasekar (Nottingham, United Kingdom), K. Binaya (Kathmandu, Nepal), P. Mahapatra (Kathmandu, Nepal), S. Puppala (Kathmandu, Nepal), D. Thakker (Nottingham, United Kingdom), J. Macisaac (Vancouver, Canada), D. Lin (Vancouver, Canada), M. Kobor (Vancouver, Canada), C. Bolton (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom), R. Clifford (Nottingham, United Kingdom)